Impact of Structured Communication in the OR on Surgical Site Infections: Prospective Observational Clinical Trial

NCT02428179 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3003

Last updated 2017-03-15

No results posted yet for this study

Summary

Surgical site infection (SSI) is the most frequent complication in patients that undergo abdominal surgery. A previous prospective observational study in 167 patients undergoing elective open abdominal procedures showed that case-relevant communication protects from organ/space SSI whereas case-irrelevant communication during the last 20 minutes of the procedure is a risk factor for incisional SSI. Therefore, the introduction of a clinical applicable intervention "structured briefing using the StOP protocol" has been developed and was tested in pilot experiments. This intervention aims at improving case-relevant communication during the procedure and to reduce excess case-irrelevant communication at the end of an operation.

The hypothesis is: structured briefings during an operation reduce the incidence of SSI after surgery.

Conditions

  • Incidence of Surgical Site Infection
  • Short Intraoperative Briefings
  • Mortality
  • Shared Mental Model

Interventions

PROCEDURE

StOP? - Control group

Control group - Surgical procedure without Study Intervention

PROCEDURE

StOP? - Intervention group

Intervention group - Surgical procedure with intraoperative briefings, optional interventions: Transparent drape between anesthesia and sterile team, Controlling noise and potential distractors during wound closure, Nutritional support during the operation

Sponsors & Collaborators

  • University of Lausanne Hospitals

    collaborator OTHER
  • Triemli Hospital

    collaborator OTHER
  • Kantonsspital Chur, Switzerland

    collaborator UNKNOWN
  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Guido Beldi, Prof. Dr. med. · Visceral and transplant surgery, University hospital, Berne

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2016-12-31
Completion
2017-01-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02428179 on ClinicalTrials.gov